Inventiva (IVA) Share-based Compensation (2020 - 2022)

Inventiva (IVA) posted quarterly Share-based Compensation of $1.7 million for Q4 2022, up 8585.42% quarter-over-quarter from $19299.8 in Q1 2021.

Inventiva (IVA) Share-based Compensation (2020 - 2022) Analysis & Trends

Inventiva's Share-based Compensation history runs 3 years deep, the most recent figure standing at $1.7 million for Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	108.10 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	243.00 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	277.20 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	137.41 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	590,899.88
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	86.63 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	41.25 Mn
10	Inventiva	888.89 Mn	888.89 Mn	-	-

Download Data